首站-论文投稿智能助手
典型文献
Hepatic hormone FGF21 and its analogues in clinical trials
文献摘要:
Fibroblast growth factor 21 (FGF21) is a fasting or stress inducible metabolic hormone produced mainly in the liver. It plays important roles in regulating both glucose and lipid homeostasis via interacting with a heterodimeric receptor complex comprising FGF receptor 1 (FGFR1) and β-klotho (KLB). For the past decade, great effort has been made on developing FGF21 derivatives or specific FGF21 receptor agonists into therapeutic agents for various metabolic disorders including type 2 diabetes (T2D), obesity, and more importantly, nonalcoholic fatty liver disease (NAFLD). Here we have reviewed FGF21 gene and protein structures, its expression pattern, cellular signaling cascades that mediate FGF21 production and function. We have then summarized the six clinical trials utilizing four FGF21 analogues. Finally, two recent literatures on the development of GLP-1 and FGF21 dual agonists were presented briefly.
文献关键词:
dual agonists;fibroblast growth factor 21;lipid metabolism;metabolic diseases
作者姓名:
Shao Weijuan;Jin Tianru
作者机构:
Division of Advanced Diagnostics, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada;Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada;Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
引用格式:
[1]Shao Weijuan;Jin Tianru-.Hepatic hormone FGF21 and its analogues in clinical trials)[J].慢性疾病与转化医学(英文),2022(01):19-25
A类:
KLB
B类:
Hepatic,hormone,FGF21,its,analogues,clinical,trials,Fibroblast,growth,fasting,stress,inducible,metabolic,produced,mainly,liver,It,plays,roles,regulating,both,glucose,lipid,homeostasis,via,interacting,heterodimeric,receptor,complex,comprising,FGFR1,klotho,For,past,decade,great,effort,has,been,made,developing,derivatives,specific,agonists,into,therapeutic,agents,various,disorders,including,type,diabetes,T2D,obesity,more,importantly,nonalcoholic,fatty,NAFLD,Here,have,reviewed,gene,protein,structures,expression,pattern,cellular,signaling,cascades,that,mediate,production,function,We,then,summarized,six,utilizing,four,Finally,two,recent,literatures,development,GLP,dual,were,presented,briefly,fibroblast,metabolism,diseases
AB值:
0.683425
相似文献
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。